Nassim Hammoudi

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Development and External Validation of a Predictive Model for Postoperative Recurrence of Crohn's Disease in the Biologic Era.

Development and External Validation of a Predictive Model for Postoperative Recurrence of Crohn's Disease in the Biologic Era.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: January 24, 2026

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Journal: United European gastroenterology journal

Published: October 19, 2025

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Journal: United European gastroenterology journal

Published: October 19, 2025

Five-year effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor.

Five-year effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor.

Journal: Clinics and research in hepatology and gastroenterology

Published: October 04, 2025

Blood proteomic signatures associated with disease activity in inflammatory bowel diseases.

Blood proteomic signatures associated with disease activity in inflammatory bowel diseases.

Journal: Journal of Crohn's & colitis

Published: September 08, 2025

Identification of a Druggable Target That Predicts Postoperative Crohn's Disease Recurrence.

Identification of a Druggable Target That Predicts Postoperative Crohn's Disease Recurrence.

Journal: Gastroenterology

Published: May 01, 2025

Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study.

Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study.

Journal: Alimentary pharmacology & therapeutics

Published: March 31, 2025

SOD mimics delivered to the gut using lactic acid bacteria mitigate the colitis symptoms in a mouse model of inflammatory bowel diseases.

SOD mimics delivered to the gut using lactic acid bacteria mitigate the colitis symptoms in a mouse model of inflammatory bowel diseases.

Journal: Free radical research

Published: March 13, 2025

Severe enterocolitis associated with phosphatidylinositol 3-kinase delta inhibitors: A multicentre cohort study.

Severe enterocolitis associated with phosphatidylinositol 3-kinase delta inhibitors: A multicentre cohort study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 16, 2025

Vedolizumab for prevention of recurrence of Crohn's disease.

Vedolizumab for prevention of recurrence of Crohn's disease.

Journal: The lancet. Gastroenterology & hepatology

Published: December 11, 2024

Metastatic perirectal PEComa treated by checkpoint inhibitor immunotherapy and multimodal treatment: case report and review of the literature.

Metastatic perirectal PEComa treated by checkpoint inhibitor immunotherapy and multimodal treatment: case report and review of the literature.

Journal: Therapeutic advances in medical oncology

Published: May 01, 2024

Systematic review: Patient-related, microbial, surgical, and histopathological risk factors for endoscopic post-operative recurrence in patients with Crohn's disease.

Systematic review: Patient-related, microbial, surgical, and histopathological risk factors for endoscopic post-operative recurrence in patients with Crohn's disease.

Journal: Alimentary pharmacology & therapeutics

Published: February 29, 2024

Showing 1-12 of 55

Last Updated: 09/26/2026